CMXHF:OTCMKTS
CSL Ltd
$126.03
arrow_downward
-1.29%(-1.65) 1D
Oct 7, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CMXHF...
Open
$126.03
High
$126.03
Low
$126.03
Mkt. cap
86.06B
Avg. vol.
122.00
Volume
0.00
52-wk high
$148.36
52-wk low
$63.84
Beta
0.56
Shares outstanding
479.88M
No. of employees
29K
Open
$126.03
High
$126.03
Low
$126.03
Mkt. cap
86.06B
Avg. vol.
122.00
Volume
0.00
52-wk high
$148.36
52-wk low
$63.84
Beta
0.56
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Haemonetics Soars 12% on CSL Update: Plasma Giant to Roll Out NexSys Across U.S. Centers
marketscreener.com
·
3 hours ago
Haemonetics Shares Gain as CSL Targets Rollout of Company's Devices by End of 2027
Investing.com Australia
·
3 hours ago
Haemonetics stock surges 17% on CSL Plasma supply deal update By Investing.com
GuruFocus
·
4 hours ago
Haemonetics (HAE) Shares Jump 14% Premarket on CSL Supply Agreem
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com